[Jefferson Home] [Hospital] [Jefferson Pulse] [Employment] [Contact Us] [Search] [News]

TJU | JMC logo
The Bottom Line: Achieving Diabetes Treatment Goals
VOLUME 1 ISSUE 1
CASE KM
VOLUME 1 ISSUE 2
CASE WM
VOLUME 1 ISSUE 3
CASE SW
VOLUME 1 ISSUE 4
CASE JJ
VOLUME 1 ISSUE 5
CASE PD
VOLUME 1 ISSUE 6
CASE MP
CASE MP
EDITORS
CME INFORMATION
DISCLAIMER
REFERENCES


REFERENCES

VOLUME 1 ISSUE 6 CASE MP

  1. Nesto RW, Bell D, Bonow, RO, et al. Thiazolidinedione use, fluid retention, and congestive heart failure. A consensus statement from the American Heart Association and American Diabetes Association. Diabetes Care. 2004;27:256–263.

  2. Bando Y, Ushiogi Y, Okafuji K, et al. Troglitazone combination therapy in obese type 2 diabetic patients poorly controlled with alpha-glucosidase inhibitors. J Int Med Res. 1999;27:53–64.

  3. Yoshimoto T, Naruse M, NIshikawa M, et al. Antihypertensive and vasculo- and reno-protective effects of pioglitazone in genetically obese diabetic rats. Am J Physiol. 1997;272;E989–E996.

  4. Baba T, Shimada K, Neurgenbauer S, et al. The oral insulin sensitizer, thiazolidinedione, increases plasma vascular endothelial growth factor in type 2 diabetic patients. Diabetes Care. 2001;24:953–954.

  5. Walker AB, Naderali EK, Chattington PD, et al. Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro. Diabetes. 1998;47:810–814.

  6. Delea TE, Edelsberg JS, Hagiwara M, et al. Use of thiazolidinediones and risk of heart failure among diabetic patients initiating new diabetes therapies. Presented at The American Diabetes Association’s Working Group on Glitazones and Heart Disease, July 2002, Chicago, IL.

  7. Braunwald E. Edema. In: Braunwald E, Fauci AS, Kasper DL, et al, eds. Harrison’s Principles of Internal Medicine, 15th ed. New York, NY: McGraw-Hill. 2001:217–222.

  8. Braunwald E. Heart Failure. In: Braunwald E, Fauci AS, Kasper DL, et al, eds. Harrison’s Principles of Internal Medicine, 15th ed. New York, NY: McGraw-Hill. 2001:1318–1329.

  9. American Diabetes Association. Hypertension management. Diabetes Care. 2004;27(suppl 1): S65–S67.

THIS ACTIVITY IS SUPPORTED BY AN UNRESTRICTED EDUCATIONAL GRANT FROM
JOINTLY SPONSORED BY  |  TJU | JMC logo  |  BIOCENTRIC INC logo


The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.

Return to Thomas Jefferson University Home Page